Drug comparisons
Saxagliptin vs Repaglinide
Saxagliptin (DPP-4 inhibitor) vs Repaglinide (meglitinide) for type 2 diabetes. Compare insulin release, hypoglycemia risk, meal dosing, weight, and safety.
No comparison dimensions are available for this page.
Clinical context
This comparison arises when selecting an oral add-on agent for type 2 diabetes between a DPP-4 inhibitor and a meglitinide insulin secretagogue.
Bottom line
Both lower blood sugar in type 2 diabetes but differ in class effects, so the better choice depends on hypoglycemia risk, meal patterns, and patient comorbidities.
All medication comparisons